DIURIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diuril, and when can generic versions of Diuril launch?
Diuril is a drug marketed by Rising and Salix Pharms and is included in two NDAs.
The generic ingredient in DIURIL is chlorothiazide. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
US Patents and Regulatory Information for DIURIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | DIURIL | chlorothiazide sodium | INJECTABLE;INJECTION | 011145-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | DIURIL | chlorothiazide | TABLET;ORAL | 011145-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Salix Pharms | DIURIL | chlorothiazide | SUSPENSION;ORAL | 011870-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
